CEACAM5 and neoplasm: Some studies, such as those by Cheong et al. [5] and Chapman et al. [6], have highlighted the potential role of carcinoembryonic antigen (CEA) as a predictive biomarker for tumor response, although evidence remains limited, and further validation in large cohorts is required.